Business · 23/08/2022Updated: 10/17/2026 · 1 min read
FDA Releases Revised Draft Guidance on Charging for Investigational Drugs Under IND
Summary
The FDA is providing a revised draft guidance on charging for investigational drugs under an IND, addressing the most recently asked questions, to replace the 2016 final guidance
Original source language: Federal Register — Food and Drug AdministrationOpen original release →